Clinical trial
AL-15469A for the Treatment of Bacterial Conjunctivitis
NCT00331916 · Alcon Research, Industry · Completed
Key facts
| NCT number | NCT00331916 |
|---|---|
| Title | AL-15469A for the Treatment of Bacterial Conjunctivitis |
| Official title | AL-15469A for the Treatment of Bacterial Conjunctivitis |
| Lead sponsor | Alcon Research, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bacterial Conjunctivitis |
| Intervention type | Drug |
| Interventions | quinolone |
| Enrollment | 600 |
| Start date | Nov 1, 2005 |
| Primary completion | May 1, 2007 |
| First posted | May 31, 2006 |
| Last update posted | Sep 29, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: